
1. General Information
POMALID 4 mg Capsules contain pomalidomide, an oral immunomodulatory agent with antineoplastic and antiangiogenic properties. It is commonly used as part of combination therapy for adults with multiple myeloma whose disease has progressed following previous treatments.
Pomalidomide belongs to the same broad drug family as thalidomide and lenalidomide but has its own clinical indications and dosing requirements.
Important: This is a potent oncology medicine and should not be purchased, started, stopped, or dose-adjusted without medical supervision.
2. Product Information
- Product: POMALID 4 mg Capsules
- Active Ingredient: Pomalidomide 4 mg
- Dosage Form: Oral capsule
- Strength: 4 mg
- Drug Class: Immunomodulatory agent / anticancer medicine
- Route: Oral
- Prescription Status: Prescription medicine
- Typical Multiple Myeloma Regimen: 4 mg once daily on Days 1–21 of a 28-day cycle, generally in combination with dexamethasone, according to the applicable prescribing information.
Product availability, brand name, approved indications, and regulatory requirements can vary by country.
3. Uses of POMALID 4 mg
Pomalidomide is used for certain adults with multiple myeloma, particularly when the disease has progressed after previous therapies including lenalidomide and a proteasome inhibitor. It is generally administered in combination with other medicines such as dexamethasone.
Pomalidomide also has approved uses for certain adult patients with Kaposi sarcoma in some regulatory jurisdictions.
The exact indication should always be confirmed against the product's local prescribing information and the treating physician's recommendation.
4. Benefits of This Medicine
When appropriately prescribed, potential therapeutic benefits include:
- Helps control certain forms of multiple myeloma.
- May help slow the growth and progression of abnormal plasma cells.
- Can be used as part of combination treatment for relapsed or refractory disease.
- Has immunomodulatory activity that can enhance certain immune-cell responses.
- May have antiangiogenic effects, helping interfere with blood-vessel formation associated with tumor growth.
The response to treatment varies between patients, and this medicine is not intended to provide a guaranteed cure.
5. Side Effects of POMALID 4 mg
Pomalidomide can cause serious as well as mild side effects. Important risks include:
- Low levels of white blood cells, red blood cells, or platelets
- Increased risk of infections
- Blood clots, including deep-vein thrombosis and pulmonary embolism
- Stroke or heart-related vascular events
- Liver toxicity
- Severe skin reactions
- Allergic or hypersensitivity reactions
- Tumor lysis syndrome in susceptible patients
Pregnancy is contraindicated because pomalidomide can cause severe, life-threatening birth defects.
6. Common Side Effects
Frequently reported adverse effects in multiple myeloma patients include:
- Fatigue or weakness
- Neutropenia
- Anemia
- Constipation
- Nausea
- Diarrhea
- Shortness of breath
- Upper-respiratory-tract infections
- Back pain
- Fever
If symptoms are severe, persistent, or unusual, the patient should contact their healthcare professional promptly.
7. How to Use POMALID 4 mg
For multiple myeloma, the FDA-approved regimen is generally 4 mg once daily on Days 1–21 of a repeated 28-day cycle, usually together with dexamethasone. The exact regimen may be modified by the treating physician depending on the patient's condition and laboratory results.
- Take the capsule exactly as prescribed.
- It can generally be taken with or without food.
- Swallow the capsule whole with water.
- Do not break, open, or chew the capsule.
- Do not change the dose without medical advice.
- If a dose is missed, follow the instructions provided by the treating physician or product medication guide.
8. How POMALID 4 mg Works
Pomalidomide works through cereblon, a component of an E3 ubiquitin ligase complex. Its activity promotes degradation of proteins such as Ikaros (IKZF1) and Aiolos (IKZF3), producing immunomodulatory and direct anticancer effects. It can inhibit the growth of certain abnormal blood cells and promote their apoptosis. It can also enhance T-cell and natural-killer-cell activity and inhibit certain inflammatory cytokines.
9. Safety Advice
Because pomalidomide has significant safety risks, patients should follow these precautions:
- Pregnancy: Do not use during pregnancy. Effective pregnancy-prevention measures and pregnancy testing are required for females of reproductive potential under applicable safety programs.
- Blood clots: Inform the doctor about previous blood-clotting problems. Preventive antithrombotic treatment may be recommended depending on individual risk.
- Blood counts: Regular blood tests are important because pomalidomide can cause neutropenia, anemia, and thrombocytopenia.
- Liver function: Liver tests may be required during treatment because hepatotoxicity can occur.
- Kidney/liver problems: The doctor may need to modify treatment in patients with significant renal or hepatic impairment.
- Breastfeeding: Breastfeeding is not recommended during treatment.
- Drug interactions: Certain medicines, including strong CYP1A2 inhibitors, may require avoidance or dose adjustment.
- Seek urgent medical attention for symptoms suggesting a blood clot, severe allergic reaction, severe rash, or serious infection.
10. FAQs
Q1. What is POMALID 4 mg Capsule?
POMALID 4 mg contains pomalidomide 4 mg, an oral immunomodulatory anticancer medicine used for certain cancers, particularly multiple myeloma.
Q2. What is POMALID 4 mg used for?
It is primarily used in certain adults with multiple myeloma after previous treatments, generally as part of combination therapy.
Q3. Can POMALID 4 mg be taken without a prescription?
No. Pomalidomide is a potent prescription oncology medicine and should be used only under appropriate medical supervision.
Q4. Can POMALID 4 mg be taken during pregnancy?
No. Pomalidomide is contraindicated during pregnancy because it can cause severe fetal harm.
Q5. Should the capsule be opened or crushed?
No. The capsule should be swallowed whole with water and should not be broken, chewed, or opened.
Q6. Does POMALID 4 mg require regular blood tests?
Yes. Blood counts and other laboratory monitoring are important because the medicine can affect blood cells and may affect liver function.
Q7. Can POMALID 4 mg be taken with food?
The multiple-myeloma regimen can generally be taken with or without food.
Q8. Is POMALID 4 mg the same as pomalidomide 4 mg?
POMALID 4 mg refers to a product containing pomalidomide 4 mg. The manufacturer and formulation should be verified from the product packaging and regulatory information.
11. Substitute for POMALID 4 mg
Possible alternatives depend on the patient's diagnosis, previous treatment, response, kidney/liver function, and oncologist's treatment plan. Pomalidomide-containing products from different manufacturers may be pharmaceutical alternatives when appropriately approved and prescribed.
Other medicines used in multiple myeloma—such as lenalidomide, bortezomib, carfilzomib, or other treatment regimens—are not automatically substitutes for POMALID 4 mg because they have different mechanisms, indications, dosing, and safety profiles.
A qualified oncologist should determine the appropriate alternative rather than substituting the medicine independently.
12. SEO / B2B Keywords
- POMALID 4 mg Capsules exporter from India
- POMALID 4 mg Capsules supplier India
- POMALID 4 mg Capsules manufacturer India
- Pomalidomide 4 mg Capsules exporter
- Pomalidomide 4 mg medicine supplier
- Pomalidomide 4 mg oncology medicine exporter
- Pomalidomide 4 mg Capsules wholesale supplier
- POMALID 4 mg Capsules pharmaceutical exporter
- Pomalidomide 4 mg Capsules bulk supplier
- Pomalidomide 4 mg for multiple myeloma
- Pomalidomide 4 mg oncology drug supplier
- POMALID 4 mg Capsules export from Nagpur India
- Pomalidomide 4 mg supplier from Nagpur
- POMALID 4 mg Capsules exporter to USA
- POMALID 4 mg Capsules exporter to UK
- POMALID 4 mg Capsules exporter to Australia
- POMALID 4 mg Capsules exporter to Singapore
- POMALID 4 mg Capsules exporter to Canada
- POMALID 4 mg Capsules exporter to South Korea
- POMALID 4 mg Capsules exporter to UAE
- Pomalidomide 4 mg pharmaceutical supplier
- Pomalidomide capsules international supplier
- Pomalidomide oncology medicine wholesale
- Pomalidomide 4 mg prescription medicine supplier
- POMALID 4 mg medicine export company
- Pomalidomide 4 mg B2B pharmaceutical supplier
- Pomalidomide 4 mg cancer medicine exporter
- POMALID 4 mg Capsules international exporter
- Pomalidomide 4 mg India pharmaceutical company
- POMALID 4 mg Capsules trusted medicine exporter
Keywords







